The global pharmaceutical vials market is expected to be valued at US$ 12,137.2 million in 2023 and reach a valuation of US$ 24,099.7 million by 2033. The demand for pharmaceutical vials is estimated to grow at a steady 7.10% CAGR, with the United Kingdom, the USA, China, and India emerging as key producers.
The market for pharmaceutical vials has seen increased demand as a result of the rise in requirements for pharmaceutical products. Advances in pharmaceutical packaging have accelerated the adoption of environmentally friendly materials. One class of materials that has gained popularity is Type I molded glass vials, largely because of their exceptional chemical makeup.
Numerous significant developments in the healthcare sector are creating new demand potential for pharmaceutical vials. The popularity of pharmaceutical vials has also been boosted by healthcare professionals and care takers' emphasis on making sure that patients take the right dosage of medication. The market for manufacturers in the biotechnology and pharmaceutical sectors has benefited from the demand for new formulations for chronic diseases in hospitalized patients.
Vials and ampoules are expected to grow, primarily due to increased consumption from emerging markets like China and India, as a result of the complexity of drugs and the rise in diseases like diabetes. About 422 million people worldwide have diabetes, according to the World Health Organization (WHO). Additionally, the use of glass vials is anticipated to increase over the forecast period as a result of factors like the rise in medical care costs caused by improper medication consumption and the growing propensity of different end-users, including hospitals and drug manufacturers.
During the coronavirus outbreak, market vendors tried their best to assist as much as they could. For example, Corning provided its products, such as glass tubing for diagnostic test kits and vials for vaccine clinical drug trials, to provide corning valor glass packaging and fill the gap for the anticipated drug shortages. Additionally, the business added glass packaging and any consumable requirements from its Life Sciences portfolio for vaccine process development.
| Attributes | Details |
|---|---|
| Pharmaceutical Vials Market CAGR (2023 to 2033) | 7.10% |
| Pharmaceutical Vials Market Size (2023) | US$ 12137.2 million |
| Pharmaceutical Vials Market Size (2033) | US$ 24,099.7 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing demand for parenteral drugs has been a key factor enabling the expansion of the pharmaceutical vials market in recent years. Between 2016 and 2020, the market grew at around 8% CAGR, says Future Market Insights (FMI) in its recent report.
| Particulars | Details |
|---|---|
| Jan-Jun (H1), 2021 (A) | 7.50% |
| Jan-Jun (H1), 2022 Projected (P) | 7.30% |
| Jan-Jun (H1), 2022 Outlook (O) | 7.70% |
| BPS: H1,2022 (O) - H1,2022 (P) | 20 |
| BPS: H1,2022 (O) - H1,2021 (P) | 40 |
Short-term growth (2023 to 2026): National Cancer Institute reports that in 2020, around 1.8 million new cancer cases were diagnosed in the USA. Rise of new cancer cases across the globe has further elevated the demand for pharmaceutical vials, especially for chemotherapy drugs.
In June 2021, Zydus Cadila Healthcare received tentative approval from the USA Food and Drug Administration (FDA) to market and sell pemetrexed in 100mg/vial, 500 mg/vial, and 1000 mg/vial, and single-dose vials for injection. Pemetrexed is a chemotherapy drug and is found effective in slowing or stopping the growth of cancer cells.
Medium-term growth (2027 to 2030): Unprecedented outbreak of the COVID-19 pandemic has increased the demand for parenteral drugs, encouraging market players to develop new pharmaceutical vials that are safe, sterile, and remain contamination free before administration. This is expected to create lucrative growth opportunities for the market.
Responding to the high demand for COVID-19 parenteral drugs, in 2021, SGD Pharma launched its new ready-to-use 20ml EasyLyo molded glass Type I vials packed in its modern secondary packaging format called “SG EZ-fill® Nest & Tub.”
The company claims that this new primary and secondary packaging combination is likely to offer biopharmaceutical producers the necessary flexibility in terms of delivering innovative medicines to patients at a faster rate.
Long-term growth (2031 to 2033): Increasing vaccination drives and high demand for parenteral drugs like insulin and corticosteroids are expected to drive the demand for pharmaceutical vials globally in the forthcoming decade.
Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients in consuming their medications in the right dosage and at the right time.
Ever since the last few decades, low medical adherence by patients has posed a critical situation for the healthcare industry as it involves the safety of the patients and causes increased healthcare spending.
To solve these issues, the healthcare industry is making constant efforts to improve the intake of medications by patients and ensure that the patients take the right dosage of drugs at the right time. In this process, the packaging of drugs and various medicines plays an important part.
Particularly in the United States, it has been reported that around 50 percent of the prescribed medications are taken incorrectly by patients. In addition, in an independent study, it was found that since patients don’t take their medications in the right manner, there are increased medical costs to the tune of US$ 200 billion.
Due to this situation, there is a demand created for such kind of pharmaceutical products that contain medications in such form that can be easily taken by the patients. This helps the patients to take the right dosage of medicines at the correct time, thus reducing their time of recovery and reducing the burden on the healthcare system as well.
Principal Consultant
Pharmaceutical Vials Market:
| Attributes | Pharmaceutical Vials Market |
|---|---|
| CAGR (2023 to 2033) | 7.10% |
| Market Value (2033) | US$ 24,099.7 million |
| Growth Factor | Growing demand for injectable drugs |
| Opportunity | Advancements in vial technology |
| Restraint | High cost of production |
Vials and Ampoules Market:
| Attributes | Vials and Ampoules Market |
|---|---|
| CAGR (2023 to 2033) | 10.5% |
| Market Value (2033) | US$ 21.97 billion |
| Growth Factor | Increasing demand for biologics and biosimilars |
| Opportunity | The growing demand for vials and ampoules in emerging markets such as Asia and Latin America is creating new opportunities for manufacturers to expand their reach. |
| Restraint | The use of plastic vials and ampoules is a concern for the environment. |
Pharmaceutical Packaging Market:
| Attributes | Pharmaceutical Packaging Market |
|---|---|
| CAGR (2023 to 2033) | 7.50% |
| Market Value (2033) | US$ 206.6 billion |
| Growth Factor | Growing emphasis on patient safety and compliance |
| Opportunity | Increasing demand for eco-friendly packaging |
| Restraint | Stringent regulatory requirements |
The demand for injectable drugs is growing due to the increasing prevalence of chronic diseases such as cancer and diabetes. As vials are a popular choice for packaging and delivering injectable drugs, this is driving the demand for pharmaceutical vials in the USA market.
There is a growing emphasis on safety and compliance in the pharmaceutical industry, driven by regulatory requirements, as well as the desire to reduce medication errors and improve patient outcomes. This is driving the demand for high-quality pharmaceutical vials that can ensure the safe and accurate delivery of medications.
Technological advancements in the production of vials, such as the use of automation and robotics, are creating new opportunities for manufacturers to produce high-quality vials at a faster rate while reducing costs. The trend toward personalized medicine is driving the demand for customized vials that can accommodate specific dosages and delivery requirements.
Overall, these factors are contributing to the growth of the pharmaceutical vials market in the United States and are expected to continue to do so in the coming years.
China is the second-largest market for pharmaceuticals globally, and it is expected to expand significantly in the upcoming years. The rising demand for medications in China is leading to an increased requirement for pharmaceutical packaging, which includes vials. There is a growing need for superior quality packaging products, including vials, as the Chinese pharmaceutical sector is developing and becoming more mature. This is because it is essential to guarantee that medications are safe and effective, and that they meet regulatory requirements.
The Chinese government has implemented policies to promote the growth of the pharmaceutical industry, such as offering tax incentives and making regulatory procedures efficient. As a result, this is making it easier for manufacturers of pharmaceutical packaging, including vials, to operate in a more favorable environment. China's middle class is expanding, which is driving the demand for high-quality healthcare products, including medicines and packaging. This presents an opportunity for manufacturers of pharmaceutical vials to offer premium and valuable products.
The pharmaceutical vials market is expected to continue to offer lucrative opportunities, and Asia Pacific is expected to play a significant role in their expansion. Outstanding developments in the pharmaceutical manufacturing sector in emerging economies, particularly India, have prodded businesses to extend their supply chains there. Over the years, the expansion of hospitals and pharmaceutical companies in those economies has increased the regional market's potential for revenue.
India is a desirable market for pharmaceutical packaging manufacturers seeking to cut costs while maintaining high standards because it has historically had lower labor and production costs than other nations. The demand for pharmaceutical packaging, including vials, is anticipated to increase further as a result of India's expanding pharmaceutical export market, opening up new business opportunities for suppliers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The plastic sub-segment in the material type category is anticipated to grow at a robust growth rate and register a CAGR of 5.1% during the period of assessment. This is a highly lucrative segment in the material type category.
As per the projections of Future Market Insights, the plastic sub-segment is estimated to touch a value of nearly US$ 7,700 million at the end of the year 2021 and is expected to touch a value of nearly US$ 12,000 million at the end of the year 2031.
The glass sub-segment is trailing the plastic sub-segment in the material type category and is projected to register a CAGR of 3.8% during the period of assessment.
The glass sub-segment is estimated to be valued at nearly US$ 2,450 million in the year 2021 and is expected to touch a value of nearly US$ 3,400 million at the end of the period of assessment in the year 2031.
As a result of the concentration of numerous pharmaceutical glass manufacturing businesses in developed regions like Europe and North America, these areas have well-established supply chains and production systems. The low labor costs and expanding opportunities offered by these nations, however, are causing manufacturers to relocate their headquarters to nations like Brazil, India, and China. In these nations, the demand for pharmaceutical glass packaging is anticipated to be driven primarily by the generic sector over the forecast period.
For instance, Gennova Biopharmaceuticals, a subsidiary of Indian pharmaceutical company Emcure Pharmaceuticals, began producing the Covid-19 vaccine in February 2022. This vaccine uses mRNA technology to target the Omicron variant. The business intends to request permission from the Drug Controller General of India (DCGI) for the clinical trials of the mRNA vaccine booster shot.
Gerresheimer AG: A global manufacturer of pharmaceutical packaging and drug delivery devices, including vials made of glass and plastic. They offer a variety of services, including design, development, and manufacturing.
Schott AG: Another global company that produces high-quality glass packaging for pharmaceuticals, including vials. They also offer services such as quality control, testing, and customization.
DWK Life Sciences Inc.: A leading manufacturer of laboratory glassware and packaging products, including vials for the pharmaceutical industry. They offer a range of materials, such as glass, plastic, and hybrid vials.
Berry Global Inc.: A key player in the plastic packaging industry, including the production of vials for pharmaceuticals. They offer a range of plastic vials, including those made of PET, PVC, and HDPE.
SGD Pharma: A European company specializing in the production of glass packaging for pharmaceuticals, including vials. They offer various types of vials made of glass, including molded and tubular vials.
The pharmaceutical vials market is slated to attain US$ 12,137.2 million in 2023.
The growth potential of the pharmaceutical vials market is 7.1% CAGR through 2033.
Surging demand for injectable drugs and increasing innovation in vial technology.
Gerresheimer AG, Schott AG, and SGD Pharma are the top market players.
Mergers and acquisitions are key strategies consolidating the key players’ position.
1. Executive Summary | Pharmaceutical Vials Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Self-Standing 5.3.2. Round Bottom 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material Type, 2023 to 2033 6.3.1. Glass 6.3.2. Plastic 6.4. Y-o-Y Growth Trend Analysis By Material Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Material Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity Size 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Capacity Size, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Capacity Size, 2023 to 2033 7.3.1. 0-1ml 7.3.2. 1-10ml 7.3.3. 10-50ml 7.3.4. 50-100ml 7.4. Y-o-Y Growth Trend Analysis By Capacity Size, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Capacity Size, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. Asia Pacific 8.3.5. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Material Type 9.2.4. By Capacity Size 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Material Type 9.3.4. By Capacity Size 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Material Type 10.2.4. By Capacity Size 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Material Type 10.3.4. By Capacity Size 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Product Type 11.2.3. By Material Type 11.2.4. By Capacity Size 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Material Type 11.3.4. By Capacity Size 11.4. Key Takeaways 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.1.4. Singapore 12.2.1.5. Thailand 12.2.1.6. Indonesia 12.2.1.7. Australia 12.2.1.8. New Zealand 12.2.1.9. Rest of Asia Pacific 12.2.2. By Product Type 12.2.3. By Material Type 12.2.4. By Capacity Size 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Material Type 12.3.4. By Capacity Size 12.4. Key Takeaways 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. GCC Countries 13.2.1.2. South Africa 13.2.1.3. Israel 13.2.1.4. Rest of MEA 13.2.2. By Product Type 13.2.3. By Material Type 13.2.4. By Capacity Size 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Material Type 13.3.4. By Capacity Size 13.4. Key Takeaways 14. Key Countries Market Analysis 14.1. USA 14.1.1. Pricing Analysis 14.1.2. Market Share Analysis, 2022 14.1.2.1. By Product Type 14.1.2.2. By Material Type 14.1.2.3. By Capacity Size 14.2. Canada 14.2.1. Pricing Analysis 14.2.2. Market Share Analysis, 2022 14.2.2.1. By Product Type 14.2.2.2. By Material Type 14.2.2.3. By Capacity Size 14.3. Brazil 14.3.1. Pricing Analysis 14.3.2. Market Share Analysis, 2022 14.3.2.1. By Product Type 14.3.2.2. By Material Type 14.3.2.3. By Capacity Size 14.4. Mexico 14.4.1. Pricing Analysis 14.4.2. Market Share Analysis, 2022 14.4.2.1. By Product Type 14.4.2.2. By Material Type 14.4.2.3. By Capacity Size 14.5. Germany 14.5.1. Pricing Analysis 14.5.2. Market Share Analysis, 2022 14.5.2.1. By Product Type 14.5.2.2. By Material Type 14.5.2.3. By Capacity Size 14.6. United Kingdom 14.6.1. Pricing Analysis 14.6.2. Market Share Analysis, 2022 14.6.2.1. By Product Type 14.6.2.2. By Material Type 14.6.2.3. By Capacity Size 14.7. France 14.7.1. Pricing Analysis 14.7.2. Market Share Analysis, 2022 14.7.2.1. By Product Type 14.7.2.2. By Material Type 14.7.2.3. By Capacity Size 14.8. Spain 14.8.1. Pricing Analysis 14.8.2. Market Share Analysis, 2022 14.8.2.1. By Product Type 14.8.2.2. By Material Type 14.8.2.3. By Capacity Size 14.9. Italy 14.9.1. Pricing Analysis 14.9.2. Market Share Analysis, 2022 14.9.2.1. By Product Type 14.9.2.2. By Material Type 14.9.2.3. By Capacity Size 14.10. China 14.10.1. Pricing Analysis 14.10.2. Market Share Analysis, 2022 14.10.2.1. By Product Type 14.10.2.2. By Material Type 14.10.2.3. By Capacity Size 14.11. Japan 14.11.1. Pricing Analysis 14.11.2. Market Share Analysis, 2022 14.11.2.1. By Product Type 14.11.2.2. By Material Type 14.11.2.3. By Capacity Size 14.12. South Korea 14.12.1. Pricing Analysis 14.12.2. Market Share Analysis, 2022 14.12.2.1. By Product Type 14.12.2.2. By Material Type 14.12.2.3. By Capacity Size 14.13. Singapore 14.13.1. Pricing Analysis 14.13.2. Market Share Analysis, 2022 14.13.2.1. By Product Type 14.13.2.2. By Material Type 14.13.2.3. By Capacity Size 14.14. Thailand 14.14.1. Pricing Analysis 14.14.2. Market Share Analysis, 2022 14.14.2.1. By Product Type 14.14.2.2. By Material Type 14.14.2.3. By Capacity Size 14.15. Indonesia 14.15.1. Pricing Analysis 14.15.2. Market Share Analysis, 2022 14.15.2.1. By Product Type 14.15.2.2. By Material Type 14.15.2.3. By Capacity Size 14.16. Australia 14.16.1. Pricing Analysis 14.16.2. Market Share Analysis, 2022 14.16.2.1. By Product Type 14.16.2.2. By Material Type 14.16.2.3. By Capacity Size 14.17. New Zealand 14.17.1. Pricing Analysis 14.17.2. Market Share Analysis, 2022 14.17.2.1. By Product Type 14.17.2.2. By Material Type 14.17.2.3. By Capacity Size 14.18. GCC Countries 14.18.1. Pricing Analysis 14.18.2. Market Share Analysis, 2022 14.18.2.1. By Product Type 14.18.2.2. By Material Type 14.18.2.3. By Capacity Size 14.19. South Africa 14.19.1. Pricing Analysis 14.19.2. Market Share Analysis, 2022 14.19.2.1. By Product Type 14.19.2.2. By Material Type 14.19.2.3. By Capacity Size 14.20. Israel 14.20.1. Pricing Analysis 14.20.2. Market Share Analysis, 2022 14.20.2.1. By Product Type 14.20.2.2. By Material Type 14.20.2.3. By Capacity Size 15. Market Structure Analysis 15.1. Competition Dashboard 15.2. Competition Benchmarking 15.3. Market Share Analysis of Top Players 15.3.1. By Regional 15.3.2. By Product Type 15.3.3. By Material Type 15.3.4. By Capacity Size 16. Competition Analysis 16.1. Competition Deep Dive 16.1.1. Schott AG 16.1.1.1. Overview 16.1.1.2. Product Portfolio 16.1.1.3. Profitability by Market Segments 16.1.1.4. Sales Footprint 16.1.1.5. Strategy Overview 16.1.1.5.1. Marketing Strategy 16.1.1.5.2. Product Strategy 16.1.1.5.3. Channel Strategy 16.1.2. Gerreshemier AG 16.1.2.1. Overview 16.1.2.2. Product Portfolio 16.1.2.3. Profitability by Market Segments 16.1.2.4. Sales Footprint 16.1.2.5. Strategy Overview 16.1.2.5.1. Marketing Strategy 16.1.2.5.2. Product Strategy 16.1.2.5.3. Channel Strategy 16.1.3. West Pharmaceutical Services, Inc. 16.1.3.1. Overview 16.1.3.2. Product Portfolio 16.1.3.3. Profitability by Market Segments 16.1.3.4. Sales Footprint 16.1.3.5. Strategy Overview 16.1.3.5.1. Marketing Strategy 16.1.3.5.2. Product Strategy 16.1.3.5.3. Channel Strategy 16.1.4. O.BERK COMPANY, LLC 16.1.4.1. Overview 16.1.4.2. Product Portfolio 16.1.4.3. Profitability by Market Segments 16.1.4.4. Sales Footprint 16.1.4.5. Strategy Overview 16.1.4.5.1. Marketing Strategy 16.1.4.5.2. Product Strategy 16.1.4.5.3. Channel Strategy 16.1.5. Adelphi Healthcare Packaging 16.1.5.1. Overview 16.1.5.2. Product Portfolio 16.1.5.3. Profitability by Market Segments 16.1.5.4. Sales Footprint 16.1.5.5. Strategy Overview 16.1.5.5.1. Marketing Strategy 16.1.5.5.2. Product Strategy 16.1.5.5.3. Channel Strategy 16.1.6. Pacific Vial Manufacturing Inc. 16.1.6.1. Overview 16.1.6.2. Product Portfolio 16.1.6.3. Profitability by Market Segments 16.1.6.4. Sales Footprint 16.1.6.5. Strategy Overview 16.1.6.5.1. Marketing Strategy 16.1.6.5.2. Product Strategy 16.1.6.5.3. Channel Strategy 16.1.7. Piramal Glass 16.1.7.1. Overview 16.1.7.2. Product Portfolio 16.1.7.3. Profitability by Market Segments 16.1.7.4. Sales Footprint 16.1.7.5. Strategy Overview 16.1.7.5.1. Marketing Strategy 16.1.7.5.2. Product Strategy 16.1.7.5.3. Channel Strategy 16.1.8. SGD SA 16.1.8.1. Overview 16.1.8.2. Product Portfolio 16.1.8.3. Profitability by Market Segments 16.1.8.4. Sales Footprint 16.1.8.5. Strategy Overview 16.1.8.5.1. Marketing Strategy 16.1.8.5.2. Product Strategy 16.1.8.5.3. Channel Strategy 16.1.9. Stevanato Group S.p.a 16.1.9.1. Overview 16.1.9.2. Product Portfolio 16.1.9.3. Profitability by Market Segments 16.1.9.4. Sales Footprint 16.1.9.5. Strategy Overview 16.1.9.5.1. Marketing Strategy 16.1.9.5.2. Product Strategy 16.1.9.5.3. Channel Strategy 16.1.10. Nipro Europe 16.1.10.1. Overview 16.1.10.2. Product Portfolio 16.1.10.3. Profitability by Market Segments 16.1.10.4. Sales Footprint 16.1.10.5. Strategy Overview 16.1.10.5.1. Marketing Strategy 16.1.10.5.2. Product Strategy 16.1.10.5.3. Channel Strategy 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports
Pharmaceutical Vials Market
